| |
| |
| Foreword | |
| |
| |
| Preface | |
| |
| |
| Introduction | |
| |
| |
| List of Abbreviations | |
| |
| |
| List of Drugs | |
| |
| |
| |
| General Considerations | |
| |
| |
| |
| The Psychiatrist as Physician | |
| |
| |
| Primary Care Psychiatry | |
| |
| |
| Differentiating Adverse Drug Effects From Primary Illness Symptoms | |
| |
| |
| The Nocebo Phenomenon and Proneness to Adverse Effects | |
| |
| |
| Negative Therapeutic Reactions | |
| |
| |
| Attribution and Causality | |
| |
| |
| Paradoxical Adverse Effects | |
| |
| |
| Extrapolating "Evidence-Based Research Findings" to "Real-World" Patients | |
| |
| |
| Dose Relationships and Adverse Effects | |
| |
| |
| FDA Warnings and Precautions | |
| |
| |
| Risk-Benefit Analyses | |
| |
| |
| General Approach to Assessing Adverse Drug Effects | |
| |
| |
| |
| Pharmacokinetics, Pharmacodynamics, and Pharmacogenomics | |
| |
| |
| Pharmacokinetics and Pharmacodynamics | |
| |
| |
| Toxic Polypharmacy | |
| |
| |
| Gender and Racial Differences in Adverse Effects | |
| |
| |
| Alcohol | |
| |
| |
| Brand Versus Generic Formulations | |
| |
| |
| Enantiomeric Versus Racemic Agents, and Parent Versus Metabolite Compounds | |
| |
| |
| Drug Blood Levels | |
| |
| |
| Pharmacogenomic Predictors of Adverse Effects | |
| |
| |
| |
| Vulnerable Populations | |
| |
| |
| Patients' Diverse Proneness to Drug Side Effects | |
| |
| |
| Children | |
| |
| |
| Medically III Patients | |
| |
| |
| Older Adults | |
| |
| |
| Patients Prone to Somatization | |
| |
| |
| |
| Adverse Psychiatric Effects of Nonpsychotropic Medications | |
| |
| |
| Analgesics | |
| |
| |
| Anticholinergics | |
| |
| |
| Anticonvulsants | |
| |
| |
| Antimicrobials | |
| |
| |
| Antineoplastics | |
| |
| |
| Antiparkinsonian Agents | |
| |
| |
| Antiretroviral Agents | |
| |
| |
| Cardiovascular Drugs | |
| |
| |
| Dermatological Agents | |
| |
| |
| Gastrointestinal Agents | |
| |
| |
| Immunosuppressants | |
| |
| |
| Interferon-� | |
| |
| |
| Oral Contraceptives and Intravaginal Rings | |
| |
| |
| Smoking Cessation Aids | |
| |
| |
| Steroids | |
| |
| |
| |
| Adverse Psychiatric Effects of Psychiatric Medications | |
| |
| |
| Activation and Mania/Hypomania or Mixed States | |
| |
| |
| Anxiety and Panic | |
| |
| |
| Clinical Trial Subjects With Psychiatric Illness | |
| |
| |
| Discontinuation Phenomena | |
| |
| |
| Disinhibition and Impaired Impulse Control | |
| |
| |
| Emotional Dulling | |
| |
| |
| Psychosis | |
| |
| |
| Suicidal Thinking or Behavior | |
| |
| |
| |
| What Nonmedical Therapists Should Know About Adverse Drug Effects | |
| |
| |
| |
| Organ Systems | |
| |
| |
| |
| Cardiovascular System | |
| |
| |
| Arrhythmias and Palpitations | |
| |
| |
| Cerebrovascular Accidents | |
| |
| |
| Dyslipidemias | |
| |
| |
| Edema | |
| |
| |
| Hypertension | |
| |
| |
| Myocarditis and Cardiomyopathy | |
| |
| |
| Orthostatic Hypotension | |
| |
| |
| |
| Dermatological System | |
| |
| |
| Alopecia | |
| |
| |
| Hyperhidrosis | |
| |
| |
| Photosensitivity | |
| |
| |
| Pruritus | |
| |
| |
| Skin Rashes | |
| |
| |
| |
| Ear, Nose, and Throat | |
| |
| |
| Bruxis | |
| |
| |
| Dysarthria | |
| |
| |
| Dysgeusia | |
| |
| |
| Oral Lesions | |
| |
| |
| Sialorrhea | |
| |
| |
| Stomatodynia (Burning Mouth Syndrome) | |
| |
| |
| Xerostomia | |
| |
| |
| |
| Electrolyte Abnormalities | |
| |
| |
| Hyponatremia and SIADH | |
| |
| |
| Metabolic Acidosis and Alkalosis | |
| |
| |
| |
| Endocrinopathies | |
| |
| |
| Bone Demineralization and Osteoporosis | |
| |
| |
| Glycemic Dysregulation and Diabetes Mellitus | |
| |
| |
| Hyperprolactinemia, Galactorrhea, and Gynecomastia | |
| |
| |
| Menstrual Disturbances and Polycystic Ovary Syndrome | |
| |
| |
| Parathyroid Abnormalities | |
| |
| |
| Thyroid Abnormalities | |
| |
| |
| |
| Gastrointestinal System | |
| |
| |
| Diarrhea, Hypermotility, and Constipation | |
| |
| |
| Gastrointestinal Bleeding | |
| |
| |
| Hepatic Impairment and Transaminitis | |
| |
| |
| Hyperammonemia | |
| |
| |
| Malabsorption Disorders | |
| |
| |
| Nausea and Gastrointestinal Upset | |
| |
| |
| Pancreatitis | |
| |
| |
| |
| Genitourinary and Renal Systems | |
| |
| |
| Dysuria and Urinary Retention | |
| |
| |
| Enuresis and Urinary Incontinence | |
| |
| |
| Nephrotic Syndrome | |
| |
| |
| Nephrotoxicity and Nephrogenic Diabetes Insipidus | |
| |
| |
| Priapism | |
| |
| |
| Renal Calculi | |
| |
| |
| Renal Insufficiency | |
| |
| |
| Sexual Dysfunction | |
| |
| |
| |
| Hematological System | |
| |
| |
| Myelosuppression: Agranulocytosis and Thrombocytopenia | |
| |
| |
| Platelet Aggregation Disorders and Bleeding Risk | |
| |
| |
| Red Blood Cells | |
| |
| |
| |
| Musculoskeletal System | |
| |
| |
| Joint Pain | |
| |
| |
| Leg Cramps | |
| |
| |
| Myalgias | |
| |
| |
| |
| Neurological System | |
| |
| |
| Akathisia and Extrapyramidal Adverse Effects | |
| |
| |
| Cognitive Complaints | |
| |
| |
| Delirium and Encephalopathy | |
| |
| |
| Dyskinesias and Dystonias | |
| |
| |
| Fatigue and Sedation | |
| |
| |
| Headache | |
| |
| |
| Motor Tics | |
| |
| |
| Muscle Twitching, Fasciculations, and Myoclonus | |
| |
| |
| Nystagmus | |
| |
| |
| Oculogyric Crises | |
| |
| |
| Paresthesias and Neuropathies | |
| |
| |
| Seizures | |
| |
| |
| Tinnitus | |
| |
| |
| Tremor | |
| |
| |
| Yawning | |
| |
| |
| |
| Ophthalmological System | |
| |
| |
| Cataracts | |
| |
| |
| Diplopia/Blurred Vision | |
| |
| |
| Glaucoma | |
| |
| |
| Retinopathies | |
| |
| |
| |
| Sleep Disturbances | |
| |
| |
| Hypersomnia and Sleep Attacks | |
| |
| |
| Insomnia | |
| |
| |
| Nightmares and Vivid Dreams | |
| |
| |
| Parasomnias | |
| |
| |
| |
| Systemic Reactions | |
| |
| |
| Allergic Reactions and Angioedema | |
| |
| |
| Antiepileptic Hypersensitivity Reactions | |
| |
| |
| Body Temperature Dysregulation | |
| |
| |
| Discontinuation Syndromes | |
| |
| |
| Drug-Induced Lupus Erythematosus | |
| |
| |
| Neuroleptic Malignant Syndrome | |
| |
| |
| Serotonin Syndrome | |
| |
| |
| Weight Gain | |
| |
| |
| Weight Loss | |
| |
| |
| |
| Pregnancy and the Puerperium | |
| |
| |
| Breast-Feeding and Adverse Events | |
| |
| |
| Growth Effects | |
| |
| |
| Teratogenicity | |
| |
| |
| Withdrawal in the Newborn | |
| |
| |
| |
| Emergency Situations | |
| |
| |
| |
| Summary Recommendations | |
| |
| |
| |
| Summary Recommendations | |
| |
| |
| The Future | |
| |
| |
| |
| Self-Assessment Questions and Answers | |
| |
| |
| |
| Resources for Practitioners | |
| |
| |
| |
| |
| |
| |